华夏时讯
喜报|华夏成像成为北京市认定机构2024年认定报备的高新技术企业 #5
In the past decade, collaboration between the imaging community and biopharma discovery teams has led to methodologies and workflows that increase the capability, throughput, and automation of cellular imaging and analysis pipelines. Unlike hypothesis-driven approaches or conventional screening assays focused on narrow research questions and a few molecular targets, morphological profiling explores broader biological questions through unbiased imaging analysis. Such approaches can maximize the efficiency of imaging pipelines and broaden the horizon for discovery beyond previously known or suspected biological associations.
2026年7月17日
